What is the dosage of Liposomal amphotericin B?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The dosage of Liposomal amphotericin B is 3-5 mg/kg daily.

Dosage Details

  • The optimal dose of lipid formulations of amphotericin B has not been determined, but a dose of 4-6 mg/kg daily is recommended based on available data 1.
  • A study demonstrated that liposomal amphotericin B at a dose of 6 mg/kg daily had an improved outcome over 3 mg/kg daily 1.
  • Another study used a mean dose of amphotericin B lipid complex of 4.4 mg/kg daily to treat cryptococcosis 1.
  • The ESCMID guideline recommends a dose of 3 mg/kg/day for liposomal amphotericin B for empiric therapy to treat possible Candida disease in adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT) 1.

Key Points

  • Liposomal amphotericin B is effective and should be considered for patients who experience renal dysfunction during therapy or have a likelihood of having renal failure 1.
  • The dosage of liposomal amphotericin B may vary depending on the specific clinical context and patient population.
  • It is essential to consult the latest clinical guidelines and evidence-based recommendations for the use of liposomal amphotericin B in specific clinical scenarios.

From the FDA Drug Label

DOSAGE & ADMINISTRATION VERIFY PRODUCT NAME AND DOSAGE. CAUTION: Under no circumstances should a total daily dose of 1. 5 mg/kg be exceeded. The recommended concentration for intravenous infusion is 0. 1 mg/mL (1mg/10mL). A single intravenous test dose (1 mg in 20 mL of 5% dextrose solution) administered over 20 to 30 minutes may be preferred. In patients with good cardio-renal function and a well tolerated test dose, therapy is usually initiated with a daily dose of 0. 25 mg/kg of body weight. However, in those patients having severe and rapidly progressive fungal infection, therapy may be initiated with a daily dose of 0.3 mg/kg of body weight. Depending on the patient's cardio-renal status, doses may gradually be increased by 5 to 10 mg per day to final daily dosage of 0.5 to 0. 7 mg/kg. Total daily dosage may range up to 1.0 mg/kg per day or up to 1. 5 mg/kg when given on alternate days.

The dosage of Liposomal amphotericin B is not directly stated in the provided drug labels, however, the dosage of amphotericin B for injection is as follows:

  • Initial dose: 0.25 mg/kg of body weight per day for patients with good cardio-renal function
  • Severe infections: 0.3 mg/kg of body weight per day
  • Maximum dose: 1.5 mg/kg per day
  • Alternate day dosing: up to 1.5 mg/kg when given on alternate days 2

From the Research

Dosage of Liposomal Amphotericin B

The recommended dosage of liposomal amphotericin B varies across different studies, but the general consensus is as follows:

  • The dosage range is between 3 to 6 mg/kg/day 3, 4, 5
  • A lower dose of 1mg/kg/day may be equally effective and a lower cost alternative for many indications 3
  • The optimal dosing remains unclear, but is generally between 3 and 5 mg/kg/day 4
  • A study found that a higher dosage of 10 mg/kg/day did not improve efficacy, but was associated with increased nephrotoxicity 6

Specific Dosage Recommendations

  • For empirical therapy in febrile neutropenia, the typical dosage is 3 mg/kg/day 6
  • For treatment of confirmed invasive fungal infections, the recommended dosage is 3-6 mg/kg/day 5
  • For treatment of disseminated histoplasmosis, the recommended dosage is 3-5 mg/kg/day 6

Key Points

  • Liposomal amphotericin B is a safe and efficacious antifungal drug for the treatment of severe invasive fungal infections 7
  • The dosage should be adjusted based on the specific indication and patient population 6
  • Nephrotoxicity is a potential side effect, but is generally less common with liposomal amphotericin B compared to other amphotericin B formulations 4, 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.